Document is current
Any future updates will be listed below
-
Authors
Cleary, Siobhan https://orcid.org/0000-0003-1741-478X
Rosen, Stuart D
Gilbert, Duncan C
Langley, Ruth E
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01327846 at ClinicalTrials.govnct02039622 at ClinicalTrials.govDocuments that mention this clinical trial
Cardiovascular health: an important component of cancer survivorship
https://doi.org/10.1136/bmjonc-2023-000090
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
https://doi.org/10.1016/s0140-6736(12)60110-x
Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure
https://doi.org/10.1016/j.amjcard.2015.10.020
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
https://doi.org/10.1016/j.ahj.2011.06.012
Circulating tumour cell clusters: isolation, biological significance and therapeutic implications
https://doi.org/10.1136/bmjonc-2024-000437
LDL cholesterol: controversies and future therapeutic directions
https://doi.org/10.1016/s0140-6736(14)61009-6
Biological agents for giant cell arteritis: treat to target
https://doi.org/10.1136/annrheumdis-2016-210061
Documents that mention this clinical trial
Cardiovascular health: an important component of cancer survivorship
https://doi.org/10.1136/bmjonc-2023-000090
-
Funding
Funding for this research was provided by:
Medical Research Council (MC_UU_00004/02)
- License Information
